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Summary
Objective: Pro-inﬂammatory cytokines play an important role in osteoarthritis (OA). In osteoarthritic cartilage, chondrocytes exhibit an alter-
ation in mitochondrial activity. This study analyzes the effect of tumor necrosis factor-a (TNFa) and interleukin-1b (IL-1b) on the mitochondrial
activity of normal human chondrocytes.
Materials and methods: Mitochondrial function was evaluated by analyzing the activities of respiratory chain enzyme complexes and citrate
synthase, as well as by mitochondrial membrane potential (Djm) and adenosine triphosphate (ATP) synthesis. Bcl-2 family mRNA expression
and protein synthesis were analyzed by RNase protection assay (RPA) and Western-blot, respectively. Cell viability was analyzed by 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) and apoptosis by 40, 6-diamidino-2-phenylindole dihydrochloride (DAPI) stain.
Glycosaminoglycans were quantiﬁed in supernatant by a dimethyl-methylene blue binding assay.
Results: Compared to basal cells, stimulation with TNFa (10 ng/ml) and IL-1b (5 ng/ml) for 48 h signiﬁcantly decreased the activity of complex I
(TNFa¼ 35% and IL-1b¼ 35%) and the production of ATP (TNFa¼ 18% and IL-1b¼ 19%). Both TNFa and IL-1b caused a deﬁnitive time-
dependent decrease in the red/green ﬂuorescence ratio in chondrocytes, indicating depolarization of the mitochondria. Both cytokines induced
mRNA expression and protein synthesis of the Bcl-2 family. Rotenone, an inhibitor of complex I, caused a signiﬁcant reduction of the red/green
ratio, but it did not reduce the viability of the chondrocytes. Rotenone also increased Bcl-2 mRNA expression and protein synthesis. Finally,
rotenone as well as TNFa and IL-1b, reduced the content of proteoglycans in the extracellular matrix of normal cartilage.
Conclusion: These results show that both TNFa and IL-1b regulate mitochondrial function in human articular chondrocytes. Furthermore, the
inhibition of complex I by both cytokines could play a key role in cartilage degradation induced by TNFa and IL-1b. These data could be im-
portant for understanding of the OA pathogenesis.
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Cartilage
Repair
SocietyIntroduction
Osteoarthritis (OA) is the most common age-related carti-
lage and joint pathology. OA is a slowly progressive degen-
erative disease characterized by degradation of the matrix
and cell death resulting in a gradual loss of articular carti-
lage integrity1,2. The chondrocyte, which is the only cell
type present in mature cartilage, is responsible for repairing
the damage tissue. Several cytokines may participate in the
pathogenesis of cartilage damage by modifying the behav-
ior of chondrocytes. In particular, interleukin-1b (IL-1b) and
tumor necrosis factor-a (TNFa) are two of the principal cyto-
kines linked to cartilage destruction3e5. However, the exact
mechanism by which enhanced cytokine production in the
cartilage modulates cartilage degradation remains unclear.
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range of metabolic intermediates. Multi-enzyme complexes
located both in the inner mitochondrial membrane and in
the mitochondrial matrix oxidize tricarboxylic acid-cycle
intermediates derived from primary nutrients6. The respira-
tory chain, located in the inner mitochondrial membrane,
consists of ﬁve multimeric protein complexes: reduced
nicotinamide adenine dinucleotide (NADH) dehydrogenasee
ubiquinone oxidoreductase (complex I), succinate dehydro-
genase (SDH)eubiquinone oxidoreductase (complex II),
ubiquinoneecytochrome c oxidoreductase (complex III),
cytochrome c oxidase (complex IV), and adenosine triphos-
phate (ATP) synthase (complex V). The respiratory chain
also requires two small electron carriers, ubiquinone (coen-
zyme Q10) and cytochrome c6,7. In mitochondrial oxidative
phosphorylation, electron transport is coupled by the four
enzyme complexes (IeIV) in the mitochondrial inner mem-
brane with ATP synthesis from adenosine diphosphate
(ADP) by complex V. The movement of electrons between
the ﬁrst four complexes of the chain produces a proton gra-
dient across the inner mitochondrial membrane, which is
one of the factors employed by complex V to generate
ATP. Mitochondria are important in regulation of cell11
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mitochondrial alterations6,7.
Mitochondrial impairment and defective oxidative phos-
phorylation have been linked to some human disorders8e10.
Cartilage, due to the absence of vascularization, is living at
2e7% oxygen level, depending on the tissue depth. As
a consequence, the activity of the mitochondrial respiratory
chain (MRC) is low, compared to vascularized tissues, and
most of the ATP molecules are coming from the glycolysis
pathway11,12. However, recently we demonstrated that the
analysis of MRC activity in OA cells showed a signiﬁcant
decrease in complex II and III activities compared to normal
chondrocytes, as well as a reduction in mitochondrial
membrane potential (Djm)
13,14. In this sense, different
ﬁndings implicate a decreased mitochondrial bioenergetic
reserve as a pathogenic factor in degenerative cartilage
disease15,16. Based on these results, we postulated that
TNFa and IL-1b could contribute to the mitochondrial alter-
ation of chondrocytes and cartilage degradation. In this
work, we demonstrate that the exposure of chondrocytes
to TNFa and IL-1b modiﬁed mitochondrial function through
a decrease in the activity of complex I of chain respiratory
mitochondrial (CRM) and ATP production, as well as a re-
duction in Djm. Besides, we show that the inhibition of com-
plex I in human articular chondrocytes could play a key role
in cartilage degradation modulated by TNFa and IL-1b.
These data could be of value for a better understanding
of the participation of TNFa and IL-1b in the pathogenesis
of OA cartilage.
Methods
CHONDROCYTE CULTURES
Normal human cartilage tissue (age 59 22 years) was
obtained at autopsy from 52 adults who had no history
of joint disease (inﬂammatory arthritis, OA, microcrystalline
arthritis and osteonecrosis). Under aseptic conditions, car-
tilage slices were removed from the condyles, minced and
treated for 15 min with trypsin 0.5 mg/ml (Sigma Chemicals,
St. Louis, MO, USA) after which the cartilage was removed
from the trypsin and treated with 2 mg/ml clostridial collage-
nase (Sigma Chemicals) in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Life Technologie, Paisley, UK), overnight
at 37(C in an orbital shaker. The digest was centrifuged
and the cells were resuspended in fetal calf serum (FCS)-
enriched DMEM and cultured in ﬂasks. Subcultures were
performed with trypsineethylenediaminetetraacetic acid
(EDTA) (Gibco) and ﬁrst-passage cells were used. Cells
were made quiescent by 48 h of incubation in the medium
containing 0.5% FCS, washed and then stimulated with
TNFa or IL-1b (R&D Systems, Abingdon, UK). This study
was approved by the Ethics Committee of Galicia (Spain).
MEASUREMENT OF CHONDROCYTE ATP LEVELS
To determine intracellular ATP levels, a luminescence
ATP detection assay system based on the production of
light caused by the reaction of ATP with added luciferase
and D-luciferin was employed (ATP, Perkin Elmer, Barce-
lona, Spain). Brieﬂy, chondrocytes were seeded at
2 104 cells per well in 96-well plates (Costar, Cambridge,
MA, USA). After incubation for 72 h, 50 ml per well of
mammalian cell lysis solution at room temperature was
added and the plate was shaken for 5 min in an orbital
shaker. Then 50 ml of substrate solution was added and
the microplate was shaken for another 5 min. The platewas dark-adapted for 10 min; the emitted light was then
measured by luminometry in a Micro Beta TriLux (Perkin
Elmer).
MEASUREMENT OF THE MRC COMPLEX ACTIVITIES
IN DIGITONIN-PERMEABILIZED CHONDROCYTES
Chondrocytes (3.5 106 per 140 mm tissue culture plate)
were collected by trypsinization of cells, washed with phos-
phate buffered saline (PBS) and sedimented at 150g for
5 min at 4(C. The pellet was resuspended in 2 ml of
ice-cold solution containing 20 mM 4-morpholinepropane-
sulphonic acid (MOPS), 0.25 M sucrose and 200 mg of dig-
itonin, per 5 106 cells. After 5 min of incubation on ice, the
suspension was centrifuged at 5000g for 3 min at 4(C. The
pellet was treated with 1.5 ml of 20 mM MOPS, 0.25 M
sucrose and 1 mM EDTA buffer, incubated for 5 min and
pelleted at 10,000g for 3 min at 4(C. The pellet was resus-
pended in 200 ml, 10 mM phosphate buffer [potassium
phosphate (KP), pH 7.4], frozen and thawed once and
then mildly sonicated. These digitonin-permeabilized chon-
drocyte homogenates (10e50 ml per 1 ml of test volume)
were used to measure the activities of the respiratory chain
enzymes and citrate synthase (CS) in a DU-650 spectro-
photometer (Beckman Instruments, Palo Alto, CA, USA).
Incubation temperatures were 30(C for rotenone-sensitive
NADH-coenzyme Q1 reductase (complex I), SDH (complex
II), antimycin-sensitive ubiquinol cytochrome c reductase
(complex III), and CS, and 38(C for cytochrome c oxidase
(complex IV).
To correct for mitochondrial volume, enzyme activities
were normalized to the speciﬁc activity of CS17. Brieﬂy,
complex I was measured by following the oxidation of
NADH at 340 nm in 20 mM KP (pH 8.0), 200 mM NADH,
1 mM NaN3, 0.1% bovine serum albumin (BSA)eEDTA,
and 100 mM ubiquinone-1 (Sigma Chemicals), in the ab-
sence of rotenone (Calbiochem, La Jolla, CA, USA) and
then in the presence of 5 mM rotenone so that a rotenone-
sensitive rate of NADH oxidation could be calculated. Com-
plex II (SDH) was assessed by following the reduction of
2,6-dichlorophenolindophenol (DCPIP) (Sigma Chemical)
at 600 nm in 50 mM TriseKP (pH 7.0), 1.5 mM potassium
cyanide (KCN) 100 mM DCPIP, and 32 mM succinate
(Sigma Chemical). Complex III was assayed by measuring
the reduction of cytochrome c at 550 nm in 50 mM KP (pH
7.5), 2 mM NaN3, 0.1% BSAeEDTA, 50 mM cytochrome c
(Roche, Barcelona, Spain) and 50 mM decyl-ubiquinol
(Sigma Chemical) in the absence of antimycin A (Sigma
Chemical) and then in the presence of 0.01 mg/ml antimy-
cin A, so that an antimycin A-sensitive rate of cytochrome
c reduction could be calculated. Complex IV was measured
by following the oxidation of reduced cytochrome c at
550 nm in 10 mM KP (pH 7.0) and 80 mM reduced cyto-
chrome (freshly prepared before each experiment by add-
ing sodium dithionite (Sigma Chemical)). CS was
evaluated at 420 nm in 75 mM TriseHCl (pH 8), 100 mM
5,50-dithiobis-(2-nitrobenzoic) acid (Sigma Chemical),
350 mg/ml acetyl-coenzyme A (Sigma Chemical), 0.5 mM
oxaloacetate (Roche), and 0.1% Triton X-100 (Sigma
Chemical).
DETERMINATION OF MITOCHONDRIAL MEMBRANE
POTENTIAL (Djm)
To measure the Djm of chondrocytes, DePsipher
(R&D) a lipophilic cation (5, 50, 6, 60-tetrachloro-1, 10, 3,
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DePsipher exists as a monomer at low values of Djm (green
ﬂuorescence) and forms aggregates at a high Djm (red ﬂuo-
rescence). Thus, mitochondria with a normal Djm concen-
trate DePsipher into aggregates (red ﬂuorescence), but
with a de-energized or depolarized Djm, DePsipher forms
monomers (green ﬂuorescence). Brieﬂy, chondrocytes
(5 105 cells per well in 6-well plate) were ﬁrst made qui-
escent by incubation for 48 h in DMEM with 0.5% FCS,
after which basal cells and cells treated with the different
stimuli were incubated for 12 h in serum-free medium. As
positive control for depolarization valinomycin 1 mM was
employed. The chondrocytes, which were collected by tryp-
sinization, were then incubated with 1 ml/ml DePsipher for
20 min at 37(C in a 5% CO2 incubator, sedimented, washed
in PBS and analyzed by ﬂow cytometry using FACScan and
Cell-Quest software (Becton Dickinson, Mountain View, CA,
USA). The analyzer threshold was adjusted on the forward
light scatter (FSC) channel to excludemost of the subcellular
debris. Photomultiplier settings were adjusted to detect DeP-
sipher monomer ﬂuorescence signals on the FL1 detector
(green ﬂuorescence, centered atw390 nm) and DePsipher
aggregate ﬂuorescence signals on the FL2 detector (red ﬂuo-
rescence, centered at w340 nm). Data analyses were
performed with Paint-a-Gate Pro Software (Becton Dickin-
son). Mean ﬂuorescence intensity values for FL1 and FL2,
expressed as relative linear ﬂuorescence channels (arbitrary
units scaled from channels 0 to 10,000) were obtained for all
experiments. In each experiment, at least 20,000 events
were analyzed.
RNA ISOLATION AND RIBONUCLEASE PROTECTION ANALYSIS
Total RNA was extracted from chondrocytes (3.5 106
per 140 mm tissue culture plate) by the guanidine isothio-
cyanateephenolechloroform method. The concentration
and purity of the RNA samples were determined by spectro-
photometry. The probe preparation for the ribonuclease pro-
tection assay was carried out according to the instructions
of the manufacturer (BD Pharmingen, Heidelberg, Ger-
many). Brieﬂy, single-strand antisense RNA probes, labeled
with a [32P]-CTP (Amersham, C¸buckinghamshire, UK) were
synthesized from linearized plasmids using T7 RNA poly-
merase (BD Pharmingen). Approximately 106 cpm of
probes were hybridized overnight at 56(C with 10e12 mg
of total RNA in 10 ml of hybridization buffer. Unhybridized
RNA was digested for 45 min at 30(C in 100 ml RNAse so-
lution. Then, 18 ml of proteinase K cocktail was added to
each sample and incubated for 15 min at 37(C to remove
the nucleases. The mixture was extracted with phenol/chlo-
roform/isoamyl alcohol and precipitated with ethanol. The
protected fragments were analyzed on a 6% TBEeUrea
gel (Invitrogen, Paisley, Scotland, UK) and by subsequent
autoradiography with X-OMAT AR ﬁlm (Eastman Kodak,
Rochester, NY, USA) with different exposition times form
Bcl-2 mRNA and L-32. To quantify the relative amounts of
mRNA of Bcl-2, the protected RNA fragments were
scanned by bidimensional laser densitometry (Amersham).
The data were standardized to the housekeeping gene L-32
(ribosomal protein p32) and the results are expressed as
the percentage of basal gene expression as arbitrary densi-
tometric units.
WESTERN-BLOT
After stimulation cells (2.5 106 per 100 mm tissue cul-
ture plate) were washed in ice-cold PBS, pH 7.5, and lysedin 0.2 M TriseHCl, pH 6.8 containing 2% SDS, 20% glyc-
erol, 1 mg/ml cocktail inhibitor, and 1 mM phenyl methyl
sulfonyl ﬂuoride (PMSF) (Sigma Chemical). Samples were
boiled for 5 min and protein concentrations were deter-
mined using a BCA reagent assay (Pierce Chemical Co.,
Rockford, IL, USA). Thirty micrograms of the protein extract
was resolved on 12.5% sodium dodecyl sulfate (SDS)-poly-
acrylamide gels and transferred to polyvinylidene diﬂuoride
membranes (Immobilon P, Millipore Co., Bedford, MA,
USA). Membranes were ﬁrst blocked in Tris buffered saline
(TBS), pH 7.4 containing 0.1% Tween-20, and 5% nonfat
dried milk for 60 min at room temperature and then incu-
bated overnight with anti-Bcl-2 (mouse anti-human Bcl-2,
1:2000, R&D, Abingdon, UK) or anti-Mcl-1 (mouse anti-
human Mcl-1, 1:500, Oncogene) in fresh blocking solution
at 4(C. After washing, the membranes were incubated
with peroxidase conjugated secondary antibodies and de-
veloped using an ECL chemiluminescence kit (Amersham).
In order to assure that equal amounts of total proteins were
charged, we also hybridized each membrane with anti a-
tubuline (Sigma Chemical).
CELL VIABILITY
Cell viability (12,000 cells per well in a 96-well plate) was
evaluated using a colorimetric assay based on the MTT as-
say (Roche Diagnostics, Mannheim, Germany). For the col-
orimetric MTT assay, 10 ml MTT, a soluble tetrazolium salt
solution (5 mg/ml in PBS), was added to the wells contain-
ing 100 ml medium and the plate was incubated for an addi-
tional 4 h. Thereafter, 100 ml of a solubilization solution
(10% SDS in 0.01 M HCl) was added to dissolve the
water-insoluble formazan salt. Quantiﬁcation of apoptosis
was then conducted with an enzyme-linked immunosorbent
assay (ELISA) reader at 570 nm (Amersham). Both pools of
cells, ﬂoating and attached chondrocytes, were employed in
these experiments as well as in the experiments to analyze
apoptosis.
HISTOLOGIC STUDY
Explants were made with a biopsy punch of 4 mm of di-
ameter, and then they were placed in complete medium
and were then incubated for 48 h with rotenone (50 mg/ml).
Finally, tissues were ﬁxed in 10% neutral buffered formalin,
dehydrated and embedded in parafﬁn according to a
standardized protocol. Sections (6 mm) were placed on
SuperFrost Plus slides (Menzel-Glaser, Germany), deparaf-
ﬁnized in xylol, hydrated in a graded series of ethanol, and
stained with hematoxylineeosin or safranin O. Sections
were visualized under Olympus BX61 Microscopy.
GLYCOSAMINOGLYCAN ASSAY
Five explants of cartilage, which were made with biopsy
punch of 4 mm of diameter, were cultured for up to 12
days in a 24-well plate with medium alone or with rotenone
(50 mg/ml). Every 4 days medium was replaced and new
stimuli were added. At day 12 supernatant was recovered
and stored at 20(C until further analyzed. The release
of proteoglycan was determined in conditioned cultured me-
dia as sulfated glycosaminoglycan (GAG) according to the
instructions of the manufacturer (Biocolor, Newtownabbey,
Northern Ireland). Brieﬂy, reaction between GAG and dye,
at acid pH, produces a dyeeGAG complex that results in
the immediate formation of turbidity, quickly followed by pre-
cipitation of the dyeeGAG complex within 10 min. Then,
1014 M. J. Lo´pez-Armada et al.: Effect of TNFa and IL-1b on mitochondrial respiratory activityGAG-bound dye is recovered to add to each tube 1 ml of
dissociation reagent. Finally, the GAG content of the
assayed samples is determined by the amount of dye that
is recovered from the sulfated GAGs in the test sample
that is measured by absorbance to 656 nm and was
expressed as ng GAG/mg weight of cartilage.
STATISTICAL ANALYSES
The data are expressed as the mean S.E.M. from deter-
minations (n) or as representative results, as indicated. In-
dividual donors were studied in duplicate or triplicate; cells
from different donors were not pooled in any experiment.
The statistical software program, SPSS (version 10.0,
SPSS, Chicago, IL, USA) was used to perform the analysis
of variance (ANOVA) or Tukey test. Differences were con-
sidered to be statistically signiﬁcant at P< 0.05.
Results
EFFECT OF CYTOKINES ON MITOCHONDRIA
The ﬁrst set of experiments was focused on studying the
effects of both pro-inﬂammatory cytokines (TNFa and IL-1b)
on mitochondrial function by analyzing the activities of
the respiratory chain enzyme complexes (IeIV) and CS,
ATP synthesis and determining the Djm. As shown in
Table I when chondrocytes are exposed to TNFa (10 ng/ml)
Table I
Modulation of mitochondrial activity induced by TNFa and IL-1b on
human chondrocytic cells
Control
(n¼ 17)
TNFa
(n¼ 10)
IL-1b
(n¼ 12)
CS enzymatic activity,
(nmoles/min/mg
protein)
117.8 14.3 125.8 12.9 122.1 8.8
MRC activityz
Complex I 28.3 2,4 18.4 2.0* 18.3 2.2*
Complex II 10.8 1.9 6.9 0.9 6.6 0.9
Complex III 56.0 3.6 58.0 7.7 55.9 4,5
Complex IV 51.2 5.3 49.1 4.5 40.9 5.0
ATP (106 M) 1.71 0.06 1.41 0.06** 1.39 0.07**
Conﬂuent chondrocytic cells were incubated for 48 h in basal
conditions or in the presence of TNFa (10 ng/ml) or IL-1b (5 ng/ml).
MRC complex activities were measured in digitonin-permeabilized
chondrocytes as reported in Methods. Values are the mean S.E.M.
CS¼ citrate synthase. zCS-corrected complex activity is expressed
as (nmoles/min/mg protein)/(CS speciﬁc activity) 100. Complex
I¼ rotenone-sensitive NADH-coenzyme Q1 reductase; Complex
II¼ succinate dehydrogenase; Complex III¼ antimycin-sensitive
ubiquinol cytochrome c reductase; and Complex IV¼ cytochrome
c oxidase. *P 0.01 of stimulated cells vs unstimulated chondro-
cytes. **P 0.05.and IL-1b (5 ng/ml) for 48 h, the activity of complex I
was signiﬁcantly decreased when compared to basal
cells (IL-1b¼ 18.3 2.2 and TNFa¼ 18.4 2.0 vs basal
¼ 28.3 2.4, P< 0.01). These reductions represent 35%
of the total activity of complex I in basal condition. The
mean values for complex II and IV in TNFa and IL-1b stim-
ulated chondrocytes were lower than that in basal cells, but
the differences were not statistically signiﬁcant. The activi-
ties of complex III and CS were similar in the three groups.
Furthermore, stimulation of cells with both IL-1b (5 ng/ml)
and TNFa (10 ng/ml) for 72 h decreased signiﬁcantly
the synthesis of ATP by 19% and 18%, respectively
(Table I).
To assess the effect of TNFa and IL-1b on the Djm
of chondrocytes, the ﬂuorescent probe DePsipher was
used. The staining pattern of DePsipher for basal chon-
drocytes was established as the standard. The total cell
population could be divided into two subsets: one with an
alteration of the Djm (green ﬂuorescence) and the other
with normal Djm (red ﬂuorescence) [Fig. 1(A)]. Both
TNFa (10 ng/ml) and IL-1b (5 ng/ml) caused a deﬁnitive de-
crease in the red/green ﬂuorescence ratio in chondrocytes,
indicating depolarization of the mitochondria [Fig. 1(B)].
These results were the consequence of a marked reduction
in the percentage of cells with normal mitochondrial
polarization (basal¼ 59 4.6%; IL-1b¼ 36 5.7%; and
TNFa¼ 40.9 6.9%) and by an increased number of cells
with mitochondrial depolarization (basal¼ 7.2 1.8%; IL-
1b¼ 16.8 2.3%; and TNFa¼ 14.1 3.0%) [Fig. 1(A)].
The mitochondrial depolarization was seen as early as
6 h, peaked at 12 h and was sustained at the highest levels
at 24 h [Fig. 1(C)].
As Bcl-2 family proteins constitute a major point control
on mitochondria activity, we studied the modulation of Bcl-
2 expression by these cytokines. The analysis of the effect
of both cytokines on the Bcl-2 family showed mRNA expres-
sion and protein synthesis induction. Both TNFa and IL-1b
elicited the mRNA expression of the Bﬂ-1, Bid, Mcl-1 and
Bax genes in a time- and dose-dependent manner
(Fig. 2). When Bcl-2 protein was evaluated, the results
showed that it was induced by TNFa and IL-1b in a time-de-
pendent manner [Fig. 3(A)]. A signiﬁcant (P< 0.05) effect
was detected at 36 h and it increased at 144 h. However,
Mcl-1 signiﬁcantly increased at 6 h and 36 h [Fig. 3(B)].
INHIBITION OF COMPLEX I ACTIVITY REPRODUCES THE
EFFECT OF TNFa AND IL-1b
To explain the functional signiﬁcance of the inhibition of
complex I activity by TNFa and IL-1b, several experiments
with rotenone, a mitochondrial complex I inhibitor, were
conducted. The distribution of the ﬂuorescence in the
population of chondrocytes demonstrated that rotenone
reduced the cell population with red ﬂuorescence
(basal¼ 50.7 3.9; rotenone¼ 45.0 3.1) [Fig. 4(A)]. Ro-
tenone caused a signiﬁcant reduction of the red/green ratioFig. 1. Mitochondrial membrane depolarization induced by TNFa and IL-1b in human chondrocytes. (A) A representative density plot for each
condition at 12 h is shown. The numbers represent the percentage of each population. (B) Histograms represent DePsipher ﬂuorescence of
normal and TNFa and IL-1b stimulated chondrocytes at 12 h. Relative to basal conditions, the green ﬂuorescence (thick line) increases while
red ﬂuorescence (thin line) decreases in TNFa or IL-1b stimulated chondrocytes. The numbers represent the red/green ﬂuorescence ratio
values of eight different experiments, each performed in duplicate (mean S.E.M.) (P< 0.05 vs control). (C) Conﬂuent human chondrocytes
were incubated for the indicated times in medium alone or with TNFa (10 ng/ml) or IL-1b (5 ng/ml) before cells were analyzed by ﬂow cytom-
etry to quantify the mitochondrial membrane potential using 5,50,6,60-tetrachloro-1,10,3,30-tetraethylbenzimidazolyl carbocyanine iodide
(DePsipher). Data acquisition was performed in a FACScan ﬂow cytometer as detailed in Methods. Valinomycin (1 mM) was employed as
a positive control for depolarization.
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1016 M. J. Lo´pez-Armada et al.: Effect of TNFa and IL-1b on mitochondrial respiratory activityFig. 2. Time course and doseeresponse of Bcl-2 family mRNA expression by TNFa and IL-1b in human chondrocytes. Conﬂuent chon-
drocytes were incubated for the indicated time intervals (6 h, 12 h and 48 h) (A), either in basal conditions or in the presence of TNF
(10 ng/ml) or IL-1 (5 ng/ml). Chondrocytes were incubated for 48 h with DMEM alone or with increasing concentrations of TNFa (0.1, 1,
and 10) (B) or IL-1b (0.05, 0.5, 5 and 12.5 ng/ml) (C). At the end of the incubation, total RNA was isolated and Bcl-2 family mRNA
expression was analyzed by the ribonuclease protection assay as reported in Methods. These blots are representatives of a total of
three experiments.
1017Osteoarthritis and Cartilage Vol. 14, No. 10Fig. 3. Time course of Bcl-2 and Mcl-1 protein synthesis by TNFa and IL-1b on human chondrocytes. (A) Conﬂuent chondrocytes were in-
cubated for the indicated time intervals (6 h, 36 h and 144 h) either in basal conditions or in the presence of TNFa (10 ng/ml) or IL-1b
(5 ng/ml). Bcl-2 protein was analyzed by Western-blot with rabbit anti-human Bcl-2. One representative blot from three experiments is shown.
(B) Conﬂuent chondrocytes were incubated for the indicated time intervals (6 h and 36 h), either in basal conditions or in the presence of TNFa
(10 ng/ml) or IL-1b (5 ng/ml). The Mcl-1 protein was analyzed by Western-blot with rabbit anti-human Mcl-1. One representative blot from three
experiments is shown.(basal¼ 3 0.2; rotenone¼ 1.8 0.13) [Fig. 4(B)]. The
study at the molecular level of the effects of rotenone
showed that it also increased Bid, Bﬂ-1 and Mcl-1 mRNA
expression, as well as Bcl-2 protein synthesis [Fig. 4(C
and D)].
INHIBITION OF COMPLEX I BY TNFa AND IL-1b IS INVOLVED
IN THE LOSS OF ECM INDUCED BY THESE CYTOKINES
Both, TNFa and IL-1b are able to reduce proteoglycan
synthesis and to induce loss of proteoglycan which leads
to matrix breakdown18,19. Thus, we assayed whether inhibi-
tion of complex I activity could mediate the effects of both
TNFa and IL-1b on the loss of extracellular matrix (ECM)
induced by cytokines. Rotenone reduced the proteoglycan
content of the ECM in the superﬁcial and middle zones, as
shown by safranin O staining in the Fig. 5(B). Quantiﬁcation
of proteoglycans after cartilage stimulation with rotenone
showed higher levels of GAG in supernatant compared
with no stimulation cartilage [Fig. 5(C)].
Finally, mitochondria play an important role in apoptosis;
both the inhibition of complex I activity and the modiﬁcation
of Djm are related to the apoptosis process. For this rea-
son, we analyzed the effects of rotenone and both cytokines
on cell viability by MTT assay. The results showed that nei-
ther stimuli were able to induce cellular death at any con-
centration and time studied [Fig. 6(A)]. Morphologic
studies by 40, 6-diamidino-2-phenylindole dihydrochloride(DAPI) did not show any cellular change characteristic of
apoptosis [Fig. 6(B)]. Additional experiments analyzing apo-
ptosis by ﬂow cytometry (DNA content in propidium iodide
stained cells) and by ELISA (DNA fragmentation) conﬁrmed
these results (data not shown).
Discussion
Recently, we demonstrated that the analysis of MRC ac-
tivity in OA chondrocytes showed a signiﬁcant decrease in
complex II and III activities compared to normal chondro-
cytes, as well as a reduction in mitochondrial membrane po-
tential (Djm)
13. TNFa and IL-1b are particularly important in
the pathophysiology of joint disease. However, the precise
contribution of TNFa and IL-1b in mitochondrial alteration
of chondrocytes and cartilage degradation remains un-
known. This is the ﬁrst study documenting the effect of
both pro-inﬂammatory cytokines, TNFa and IL-1b, on the
activities of the MRC complexes (complex IeIV) and CS,
and also on the Djm in cultured human normal chondro-
cytes with possible implications for OA.
After chondrocytes stimulation with TNFa and IL-1b, ac-
tivity of complex I was decreased in a 35% vs total activity
of complex I (rotenone-sensitive NADH-coenzyme) in basal
condition. We measured respiratory chain complexes nor-
malized to CS activity, because this enzyme is considered
to be a marker of mitochondrial mass20,21. Therefore, the ra-
tio of the speciﬁc respiratory complex/CS activity indicates
1018 M. J. Lo´pez-Armada et al.: Effect of TNFa and IL-1b on mitochondrial respiratory activityFig. 4. Rotenone-induced membrane depolarization and Bcl-2 expression in human chondrocytes. (A) Conﬂuent human chondrocytes were
incubated for 12 h in medium alone or with rotenone (50 mg/ml) before cells were analyzed by ﬂow cytometry to quantify the mitochondrial
membrane potential using 5,50,6,60-tetrachloro-1,10,3,30-tetraethylbenzimidazolyl carbocyanine iodide (DePsipher). The numbers represent
the percentage of each population. (B) Histograms represent the DePsipher ﬂuorescence of normal and rotenone-stimulated chondrocytes.
Relative to the basal conditions, green ﬂuorescence (thick line) increases while red ﬂuorescence (thin line) decreases in rotenone-stimulated
chondrocytes. The numbers represent the red/green ﬂuorescence ratio values of eight different experiments, each performed in duplicate
(mean S.E.M.) (P< 0.05 vs control). For Bcl-2 mRNA expression (C), chondrocytes were incubated for 6 h with DMEM alone or with rotenone
(50 mg/ml). At the end of the incubation, total RNA was isolated and processed as described in Methods. This blot is representative of a total of
three experiments. (D) Chondrocytes were incubated for the indicated time in medium alone or in the presence of 50 mg/ml rotenone. The
whole cell lysate was obtained as described in Methods, and Bcl-2 protein was determined by immunoblot analyses. Tubuline levels were
used to conﬁrm the equal loading of samples. This blot is representative of a total of three experiments.
1019Osteoarthritis and Cartilage Vol. 14, No. 10whether differences in complex activities are due to the en-
richment in mitochondrial proteins or result from a change in
mitochondrial metabolic function. These results are in
agreement with other reported observations showing that
MRC complex I was inhibited by TNFa in Myelogenous leu-
kemia cell line22. Similarly, TNFa and IL-1b exposure of the
cardiomyocytes resulted in a selective oxygen consumption
of the respiratory chain complexes I and II decreased by up
to 45%23.
These results differ from those that reported OA chondro-
cytes show a signiﬁcant reduction in the activities of com-
plexes II and III13. However, examination in more detail of
those results showed a quasi signiﬁcant reduction in the ac-
tivity of complex I (P¼ 0.06). At the same time, the results
reported here also show an important numerical reduction
in complex II activity with a trend to statistical signiﬁcance
(basal: 10.8 1.9 vs IL-1: 6.6 0.9 and TNF: 6.9þ 0.9).
Fig. 5. Effect of rotenone on the ECM of human cartilage punches.
Cartilage punches were incubated for 48 h in (A) medium alone and
(B) rotenone (50 mg/ml). Tissues were stained with safranin O to
detect proteoglycans in the ECM. A picture shows that rotenone
induces a loss of stain in the superﬁcial and middle zones of the
cartilage. (C) Effect of rotenone on GAG’s release. Human articular
cartilage explants were incubated for 12 days in medium alone or
with rotenone (50 mg/ml). At the indicated times GAGs were
measured from the supernatants as described under Methods.
Data are expressed as ng/mg protein, and represent the mean
S.E.M. of ﬁve independent experiments by duplicate (*P 0.05 vs
control).All these data suggest that both complex I and II activities
could be reduced in OA chondrocytes and in normal chon-
drocytes stimulated with TNFa or IL-1b, respectively.
A possible explanation for the discrepancy with the data
reported previously by us, is that TNFa induces a functional
modiﬁcation of complex I activity. This participation of com-
plex I activity in TNF-induced mitochondrial modiﬁcation
could be regulated by substrate availability rather than by
a permanent modiﬁcation of complex I proteins22,24. How-
ever, alterations of MRC activities reported by our group
in OA are permanent and deﬁnitive because they were
shown in chondrocytes after several weeks in culture.
These permanent modiﬁcations can be performed by sev-
eral mutagen molecules such as nitric oxide (NO) or reac-
tive oxygen species (ROS) localized in the synovial ﬂuid
of OA joints at high concentrations25,26. Then it is possible
that OA chondrocytes express permanent alteration of com-
plex II and III caused by mutations of DNA, and both cyto-
kines (TNFa and IL-1b) induce a functional and reversible
modiﬁcation in the complex I. The combination of both ef-
fects (permanent and functional alteration of mitochondrial
complexes) could cause a stronger modiﬁcation of mito-
chondrial activity.
Inhibition of the MRC by rotenone, a speciﬁc inhibitor of
complex I, has been widely used to study the role of the
MRC in several biologic processes20,24,27,28. In this paper,
to explain the functional signiﬁcance of the inhibition of
complex I activity by TNFa and IL-1b, several experiments
with rotenone were conducted. Interestingly, rotenone
reproduced several effects mediated by both cytokines. It
decreased Djm, increased the Bﬂ-1 and Mcl-1 mRNA
expression and Bcl-2 protein synthesis.
Furthermore, rotenone, as well as TNFa and IL-1b,
caused depletion of GAGs in the ECM with a histologic pat-
tern similar to described after cartilage stimulation with both
cytokines. TNFa and IL-1b are catabolic cytokines involved
in cartilage degradation. The involvement of IL-1b in carti-
lage degradation was established from studies showing
that intra-articular administration of IL-1b in rabbit and
mouse joints resulted in prolonged loss of proteoglycans
from the cartilage3e5,18. In this sense, studies in OA animal
models have also demonstrated chondroprotective effects
of anticytokine therapy18,29. We have conﬁrmed previous
results showing that both cytokines in vitro caused a deple-
tion of proteoglycans in the superﬁcial and middle zones of
human normal cartilage (data not shown). A possible expla-
nation for the depletion of proteoglycans by both cytokines
could be the reduction of cell viability. However, we have
demonstrated that both cytokines, and also rotenone, in
our experimental conditions, are not capable of inducing
cell death in chondrocyte.
Other mechanisms can explain the effect of both TNFa
and IL-1b on the depletion of proteoglycans. Both cytokines
are able to reduce proteoglycan synthesis. Biosynthesis of
aggrecans requires ATP and nicotinamide adenine dinucle-
otide phosphate (reduced) (NADPH). Cytokines could in-
duce a decrease of NADPH supply at the level of pentose
phosphate pathway, which could in turn take a part in the
down-regulation of aggrecan synthesis24. Furthermore,
cytokines induce matrix metalloproteinases (MMPs) activity,
and increase the synthesis of NO or ROS. Inhibition of com-
plex I with rotenone also reduced the proteoglycan content
of the ECM in the superﬁcial and middle zones and it
increased the release of GAGs from cartilage to superna-
tant. Under physiological conditions, the MRC is one of the
most important sites of ROS production24,26. In chondrocytes
ROS are produced in the membrane NADPH-oxidase and
1020 M. J. Lo´pez-Armada et al.: Effect of TNFa and IL-1b on mitochondrial respiratory activityFig. 6. TNFa, IL-1b and rotenone do not induce cell death in human chondrocytes. (A) Human chondrocytes were incubated in 96-well plates in
basal conditions or with TNFa (10 ng/ml) or IL-1b (5 ng/ml) or rotenone (50 mg/ml). At 48 h cell viability was evaluated in both ﬂoating and attached
cells using a colorimetric analyze based on theMTT assay. Data are expressed as percentages with respect to control conditions, and represent
themean SE of six independent experiments in triplicate. (B) Fluorescent micrographs are fromDAPI untreated cells, and cells treated for 36 h
with TNFa (10 ng/ml) or with IL-1b (5 ng/ml) or rotenone (50 mg/ml). All conditions show the normal morphology of chondrocyte nucleus.in the MRC30. In other cell types, such as macrophages or
astrocytes, two sites in the respiratory chain, complex I and
complex III, have been suggested to be the major ROS
source31,32. However, the inhibition of complex I by rote-
none in human chondrocytes does not modify basal and
IL-1-induced NO synthesis (data not shown) as it was
reported in other cell types33.
Finally, chondrocytes activated by cytokines produce
ECM-degrading enzymes; this process is associated with
proteoglycan depletion. It was reported that rotenone in-
duced up-regulation of gene sets involved in mitochondrial
chaperone activity, protein degradation (proteases), respira-
tory chain assembly and division34. Several mechanisms to
explain the effect of rotenone on gene expression have been
described. Rotenone impeded ascorbate biosynthesis,
demonstrating a link between complex I activity and synthe-
sis of a key cellular anti-oxidant. The reduction of ascorbate
levels may result in markedly increases of oxidized proteins.
Furthermore, the activity of the proteosome system degrad-
ing oxidized proteins was reduced intensely after treatment
with rotenone35,36. However, the capacity of mitochondria
to induce the synthesis of MMPs in human chondrocytes
is actually unknown and represents an attractive mechanism
currently under study in our laboratory.Cartilage is a tissue inﬂuenced by acting factors both in
epiphyseal zone (deep zone) and synovial ﬂuid or synovium
(superﬁcial zone). Several lines of experimentation suggest
that provision of glucose and oxygen supplied from synovial
ﬂuid may be critical particularly for chondrocytes in deep
zone11,12, and that an anaerobic glycolysis and lactate
production are involved in respiratory metabolism of articu-
lar cartilage even in aerobic conditions11,37. In our case,
chondrocytes from superﬁcial and deep zones were kept in
standard media with high glucose concentration (4.5 mM)
and aerobic conditions that could lead to cells to obtain
their energy predominantly from an anaerobic glycolysis.
For this reason, it is likely that the effect of cytokines
observed here, in cultures maintained in normal atmosphere,
is even more crucial in vivo, where the mitochondrial activity
is probably lower.
Taken together, our results indicate that both cytokines,
TNFa and IL-1b, modiﬁed mitochondrial function by a mech-
anism involving decrease in the activity of complex I of
CRM and ATP production, as well as a reduction in Djm in
human chondrocyte cells. These data suggest that inhibition
of complex I may play an important role in the cartilage deg-
radation modulated by TNFa and IL-1b. The present data
support the idea that development of complex I activators
1021Osteoarthritis and Cartilage Vol. 14, No. 10may represent a novel therapeutic approach for cartilage
degradation diseases. These data also could be important
for a better understanding of the participation of TNFa and
IL-1b in the pathogenesis of inﬂammatory arthropathies.
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